United States· US:70000-0502_5944f7bf-c84b-497f-e063-6394a90aed1f
Leader Dry Eye Relief Eye Drops
A medicinal product containing glycerin; hypromellose, unspecified; polyethylene glycol 400, registered in United States by CARDINAL HEALTH 110, LLC. DBA LEADER.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400
- Manufacturer
- CARDINAL HEALTH 110, LLC. DBA LEADER
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1170000-0502-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/214bf1be-b534-4a88-8463-9ad14f5c4f7f GET /v1/drugs/214bf1be-b534-4a88-8463-9ad14f5c4f7f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": ".2; .2; 1",
"substance": "GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400",
"productndc": "70000-0502",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "g/100mL; g/100mL; g/100mL",
"application_number": "M018",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about glycerin; hypromellose, unspecified; polyethylene glycol 400.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.